Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 861177 NEW YORK, NY

Position in MIRM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,045,634
+$1,890,450 QoQ
Shares Held
68,725
+3.1% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#99
of 327 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 48% Shared 0% None 52%

Common Shares in MIRM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. MIRM ranks #47 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MIRM

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,045,634 68,725
2026-03-31 $6,155,184 66,629
2025-12-31 $4,676,283 59,201
2025-09-30 $4,449,841 60,699
2025-06-30 $8,218,223 161,490
2025-03-31 $6,735,784 149,518
2024-12-31 $3,055,268 73,888
2024-09-30 $2,474,979 63,461
2024-06-30 $2,052,048 60,019
2024-03-31 $1,032,556 41,105
2023-12-31 $1,204,562 40,805
2023-09-30 $1,226,395 38,810
2023-06-30 $591,103 22,849
2023-03-31 $548,832 22,849
2022-12-31 $393,197 20,164